Navigation Links
Halozyme Confirms Baxter Has Received A Complete Response Letter For HyQ BLA
Date:8/1/2012

SAN DIEGO, Aug. 1, 2012 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the Center for Biologics Evaluation and Research (CBER) of the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL) for Baxter's HyQ Biologics License Application (BLA). HyQ is an investigational product that includes plasma-derived Immune Globulin (IG) 10% and Halozyme's recombinant human hyaluronidase (rHuPH20) for subcutaneous administration in patients with primary immunodeficiency disease.

(Logo:  http://photos.prnewswire.com/prnh/20100302/LA63139LOGO )

The letter requested additional preclinical data to support the BLA. The primary issues raised in the letter focused on non-neutralizing antibodies generated against recombinant human hyaluronidase and the possible effects of these antibodies on reproduction, development and fertility. Elevated anti-rHuPH20 antibody titers were detected in the registration trial, but have not been associated with any adverse events.

Pending the parties providing additional preclinical data sufficient to address the regulatory questions, CBER has requested that patients should no longer be dosed with rHuPH20 in the Baxter and ViroPharma clinical studies.

Halozyme has been in contact with the Center for Drug Evaluation and Research (CDER) regarding the impact on Hylenex® recombinant (hyaluronidase human injection). CDER is the division of FDA regulating the other investigational rHuPH20 programs, including insulin and PEGPH20. After reviewing the data, CDER has confirmed that there is no need for actions against Hylenex or clinical programs in the Hylenex IND.

"With receipt of the CRL, we can directly address the questions raised by CBER," said Gregory I. Frost, Ph.D., President and Ch
'/>"/>

SOURCE Halozyme
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Halozymes Ultrafast Insulin Formulations Improved Postprandial Glycemic Control in Patients Living with Type 1 Diabetes: Phase 2 Study Results Presented at ADA 2012
2. Halozyme Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
3. Halozyme Reports First Quarter 2012 Financial Results
4. Halozyme to Host First Quarter 2012 Financial Results Conference Call
5. Lilly Confirms Date and Conference Call for Second-Quarter 2012 Financial Results Announcement
6. Study Confirms Daniels Sharpsmart Helps Hospitals Reduce Carbon Footprint
7. Watson Confirms Testim® Patent Challenge
8. Watson Confirms Lo Loestrin® Fe Patent Challenge
9. Sirnaomics Received NIH SBIR Grant for Developing Its Scarless Wound Healing siRNA Therapeutics
10. Hologic Completes Acquisition Of Gen-Probe
11. United Seating & Mobility Completes Acquisition of Active American Mobilitys Rehab Division
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... LAUDERDALE, Fla. , July 2, 2015 /PRNewswire/ ... Co., is pleased to announce that its Consumer ... ("Insight Beverages") to Kerry Group plc (ISE: KRZ) ... on taste and nutrition systems, as well as ... beverage and pharmaceutical markets. Farlie Turner served as ...
(Date:7/2/2015)... , July 2, 2015 Roche,s ... conspicuously high-growth market segment in hematology testing, according ... said that Roche,s recent unveiling of its Bloodhound digital ... cobas m 511 hematology analyzer – ... capture growth enjoyed by current leader CellaVision, but ...
(Date:7/2/2015)... , June 25, 2015 Research ... "Cancer Diagnostics Market by Technology, Imaging and by Application - Forecast ... cancer diagnostics market is expected to reach $13.1 Billion in 2020 ... of 12.9%. The market is dominated by ... Asia , and Rest of the World (RoW). ...
Breaking Medicine Technology:Farlie Turner's Consumer Group Completes Sale of Insight Beverages to Kerry 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 3Global Cancer Diagnostics Market Report 2015 - Technology, Imaging and by Applications Forecasts to 2020 for the $13 Billion Industry 2
(Date:7/3/2015)... ... July 03, 2015 , ... First Choice Emergency Room , the largest ... MD as the new Medical Director of its Frisco facility. , “We are pleased ... facility,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:7/2/2015)... ... 2015 , ... sweetFrog Enterprises, LLC. is pleased to announce the opening of ... located in Mississippi. The premium frozen yogurt chain was listed as #22 on the ... 104 Railroad Avenue, New Albany, MS 38652, will have a grand opening event on ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... retrofit project at the University of Minnesota, they knew it would save the ... also be an award-winning choice: the total energy savings after installation was an ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... As Americans ... like the hot temps, skin cancer is on the rise. July is UV Safety ... are raising awareness about the importance of getting skin checks. Experts say most skin ...
(Date:7/2/2015)... ... 02, 2015 , ... ActiveBunch.com recently launched as a social network created for ... as a lifestyle community, Active Bunch allows users to connect with like-minded fitness enthusiasts ... in discussions or group events. , The spokesperson for Active Bunch explained the ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:sweetfrog Opens First Location in Mississippi 2Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2Health News:Local Physicians Warn of Holiday Health Hazards 2Health News:Local Physicians Warn of Holiday Health Hazards 3Health News:Local Physicians Warn of Holiday Health Hazards 4Health News:ActiveBunch.com Launches as a Social Community for People with Active Lifestyles 2
... Arabia, is confirmed to be released from the prison in ... on charges of causing partial blindness to a Saudi national. ... media glare for quite a while. Naushad’s release was ... the injury caused. This happened during the visit of Saudi ...
... problem due to the new Medicare drug plan. Each plan has ... These plans require the patients to obtain prior authorization from ... for prior authorization for different drugs. Most states have at least ... plans make the system complicated and delay the access of the ...
... underwent a heart transplant and the doctors are happy that the ... boy underwent a heart transplant surgery at the Edmonton hospital ... pediatric heart transplant centre for the Prairies. ,His problem ... ultrasound performed at the 20th week of pregnancy revealed the problem ...
... Health Organisation) today projected that by 2020 road accidents ... outranking public health issues like tuberculosis, diarrhoea and HIV/AIDS.// ... are expected to increase from 135,000 in 2000 to ... from road crashes, according to a WHO report 'World ...
... 41 hernia surgeries in 13 hours, 41 minutes and 19 ... Chennai. // ,The surgeon Dr J S Rajkumar, chairman, ... 41 surgeries in 24 hours. ,The patients on ... surgical exercise was backed by a team of dedicated professionals ...
... edition of the British Dental Journal says that although the ... the early signs and symptoms of the same is way ... London and Guy's, King's and St Thomas' Dental Institute found ... cancer or mouth cancer as compared to 56 percent awareness ...
Cached Medicine News:Health News:Medicare Drug Plans Are Onerous and Restrictive 2Health News:Road accidents greater threat than AIDS, TB: WHO 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: